| Diagnosis & treatment of tuberculosis in HIV co-infected patients C Padmapriyadarsini, G Narendran, S Swaminathan Indian Journal of Medical Research 134 (6), 850-865, 2011 | 192 | 2011 |
| HIV-associated tuberculosis: clinical update S Swaminathan, C Padmapriyadarsini, G Narendran Clinical Infectious Diseases 50 (10), 1377-1386, 2010 | 156 | 2010 |
| Impact of HIV infection on the recurrence of tuberculosis in South India S Narayanan, S Swaminathan, P Supply, S Shanmugam, G Narendran, ... The Journal of infectious diseases 201 (5), 691-703, 2010 | 147 | 2010 |
| HIV and tuberculosis in India S Swaminathan, G Narendran Journal of biosciences 33 (4), 527-537, 2008 | 134 | 2008 |
| Mycobacterial Antigen Driven Activation of CD14++CD16− Monocytes Is a Predictor of Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome BB Andrade, A Singh, G Narendran, ME Schechter, K Nayak, ... PLoS pathogens 10 (10), e1004433, 2014 | 132 | 2014 |
| Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial S Swaminathan, G Narendran, P Venkatesan, S Iliayas, ... American journal of respiratory and critical care medicine 181 (7), 743-751, 2010 | 124 | 2010 |
| Paradoxical tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in HIV patients with culture confirmed pulmonary tuberculosis in India and the potential role of … G Narendran, BB Andrade, BO Porter, C Chandrasekhar, P Venkatesan, ... PloS one 8 (5), e63541, 2013 | 121 | 2013 |
| Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis F Fregonese, SD Ahuja, OW Akkerman, D Arakaki-Sanchez, I Ayakaka, ... The lancet respiratory medicine 6 (4), 265-275, 2018 | 104 | 2018 |
| Efficacy and safety of once-daily nevirapine-or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial S Swaminathan, C Padmapriyadarsini, P Venkatesan, G Narendran, ... Clinical Infectious Diseases 53 (7), 716-724, 2011 | 87 | 2011 |
| CYP2B6 G516T Polymorphism but Not Rifampin Coadministration Influences Steady-State Pharmacokinetics of Efavirenz in Human Immunodeficiency Virus … G Ramachandran, AK Hemanth Kumar, S Rajasekaran, P Kumar, ... Antimicrobial agents and chemotherapy 53 (3), 863-868, 2009 | 86 | 2009 |
| 5′ regulatory and 3′ untranslated region polymorphisms of vitamin D receptor gene in South Indian HIV and HIV–TB patients K Alagarasu, P Selvaraj, S Swaminathan, G Narendran, PR Narayanan Journal of clinical immunology 29, 196-204, 2009 | 74 | 2009 |
| Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome HY Tan, YK Yong, BB Andrade, EM Shankar, S Ponnampalavanar, ... Aids 29 (4), 421-431, 2015 | 72 | 2015 |
| Increasing nevirapine dose can overcome reduced bioavailability due to rifampicin coadministration G Ramachandran, AK Hemanthkumar, S Rajasekaran, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 42 (1), 36-41, 2006 | 72 | 2006 |
| Mannose binding lectin gene variants and susceptibility to tuberculosis in HIV-1 infected patients of South India K Alagarasu, P Selvaraj, S Swaminathan, S Raghavan, G Narendran, ... Tuberculosis 87 (6), 535-543, 2007 | 64 | 2007 |
| Efficacy of a six-month versus a 36-month regimen for prevention of tuberculosis in HIV-infected persons in India: a randomized clinical trial S Swaminathan, PA Menon, N Gopalan, V Perumal, ... PloS one 7 (12), e47400, 2012 | 58 | 2012 |
| Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial RL Goodall, SK Meredith, AJ Nunn, A Bayissa, AK Bhatnagar, G Bronson, ... The Lancet 400 (10366), 1858-1868, 2022 | 57 | 2022 |
| Association of high T allele frequency of CYP2B6 G516T polymorphism among ethnic south Indian HIV-infected patients with elevated plasma efavirenz and … G Ramachandran, K Ramesh, AK Hemanth Kumar, I Jagan, M Vasantha, ... Journal of antimicrobial chemotherapy 63 (4), 841-843, 2009 | 57 | 2009 |
| CD209 gene polymorphisms in South Indian HIV and HIV-TB patients P Selvaraj, K Alagarasu, S Swaminathan, M Harishankar, G Narendran Infection, Genetics and Evolution 9 (2), 256-262, 2009 | 53 | 2009 |
| Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis N Gopalan, P Chandrasekaran, S Swaminathan, S Tripathy AIDS research and therapy 13, 1-19, 2016 | 52 | 2016 |
| TB–HIV co‐infection: a catastrophic comradeship G Narendran, S Swaminathan Oral diseases 22, 46-52, 2016 | 49 | 2016 |
